{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:26:15Z","timestamp":1790871975282,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1038\/s41440-020-0529-7","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T03:03:37Z","timestamp":1596769417000},"page":"1413-1420","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Abdominal aortic calcification is more severe in unilateral primary aldosteronism patients and is associated with elevated aldosterone and parathyroid hormone levels"],"prefix":"10.1038","volume":"43","author":[{"given":"Tilakezi","family":"Tuersun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,7]]},"reference":[{"key":"529_CR1","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab. 2008;93:3266\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"529_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","volume":"58","author":"T Nishikawa","year":"2011","unstructured":"Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, et al. The Task Force Committee on Primary Aldosteronism, the Japan Endocrine Society. Guidelines for the diagnosis and treatment of primary aldosteronism-the Japan Endocrine Society 2009[J]. Endocr J. 2011;58:711\u201321.","journal-title":"Endocr J"},{"key":"529_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis[J]. Lancet Diabetes Endocrinol. 2018;6:41\u201350.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"529_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","volume":"62","author":"S Savard","year":"2013","unstructured":"Savard S, Amar L, Plouin PF, Steichen O. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study[J]. Hypertension. 2013;62:331\u20136.","journal-title":"Hypertension"},{"key":"529_CR5","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1210\/jc.2013-2805","volume":"98","author":"P Mulatero","year":"2013","unstructured":"Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A. et al. Long-term cardio-and cerebrovascular events in patients with primary aldosteronism[J]. J Clin Endocrinol Metab. 2013;98:4826\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"529_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/VHRM.S4822","volume":"5","author":"RJ Rennenberg","year":"2009","unstructured":"Rennenberg RJ, Kessels AG, Schurgers LJ, van Engelshoven JM, de Leeuw PW, Kroon AA. Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis[J]. Vasc Health Risk Manag. 2009;5:185\u201397.","journal-title":"Vasc Health Risk Manag"},{"key":"529_CR7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.117.10644","volume":"71","author":"P Liu","year":"2018","unstructured":"Liu P, Zhang S, Gao J, Lin Y, Shi G, He W, et al. Downregulated serum 14, 15-epoxyeicosatrienoic acid is associated with abdominal aortic calcification in patients with primary aldosteronism[J]. Hypertension. 2018;71:592\u20138.","journal-title":"Hypertension"},{"key":"529_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejphar.2016.05.030","volume":"786","author":"J Gao","year":"2016","unstructured":"Gao J, Zhang K, Chen J, Wang MH, Wang J, Liu P, et al. Roles of aldosterone in vascular calcification: an update[J]. Eur J Pharm. 2016;786:186\u201393.","journal-title":"Eur J Pharm"},{"key":"529_CR9","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/ijms18040848","volume":"18","author":"B Fabrizio","year":"2017","unstructured":"Fabrizio B, Silvia M, Tracy W, Denis R, Jacopo B, Martina T, et al. Subtype diagnosis of primary aldosteronism: is adrenal vein sampling always necessary?[J]. Int J Mol Sci. 2017;18:848.","journal-title":"Int J Mol Sci"},{"key":"529_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fendo.2016.00072","volume":"7","author":"N El Ghorayeb","year":"2016","unstructured":"El Ghorayeb N, Bourdeau I, Lacroix A. Role of ACTH and other hormones in the regulation of aldosterone production in primary aldosteronism[J]. Front Endocrinol. 2016;7:72.","journal-title":"Front Endocrinol"},{"key":"529_CR11","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1097\/HJH.0000000000001488","volume":"35","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Niu W, Zheng F, Zhang H, Zhu L. Identifying unilateral disease in Chinese patients with primary aldosteronism by using a modified prediction score[J]. J Hypertens. 2017;35:2486.","journal-title":"J Hypertens"},{"key":"529_CR12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/HYPERTENSIONAHA.112.195891","volume":"60","author":"GP Rossi","year":"2012","unstructured":"Rossi GP, Ragazzo F, Seccia TM, Maniero C, Barisa M, Calo LA, et al. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma[J]. Hypertension. 2012;60:431\u20136.","journal-title":"Hypertension"},{"key":"529_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/ajh\/hpv146","volume":"29","author":"LX Zhang","year":"2015","unstructured":"Zhang LX, Gu WJ, Li YJ, Wang Y, Mu YM. PTH is a promising auxiliary index for the clinical diagnosis of aldosterone-producing adenoma[J]. Am J Hypertens. 2015;29:575\u201381.","journal-title":"Am J Hypertens"},{"key":"529_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2165\/11311730-000000000-00000","volume":"17","author":"F Fortina","year":"2010","unstructured":"Fortina F, Bellosta S. Hyperparathyroidism secondary to hyperaldosteronism[J]. High Blood Press Cardiovasc Prev. 2010;17:27\u201330.","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"529_CR15","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.surg.2009.09.041","volume":"146","author":"L Brunaud","year":"2009","unstructured":"Brunaud L, Germain A, Zarnegar R, Rancier M, Alrasheedi S, Caillard C, et al. Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism[J]. Surgery. 2009;146:1035\u201341.","journal-title":"Surgery"},{"key":"529_CR16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/ajh\/hpu102","volume":"28","author":"K Chau","year":"2014","unstructured":"Chau K, Holmes D, Melck A, Clifford Chan-Yan. Secondary hypertension due to concomitant aldosterone-producing adenoma and parathyroid adenoma[J]. Am J Hypertens. 2014;28:280\u20132.","journal-title":"Am J Hypertens"},{"key":"529_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.metabol.2013.08.016","volume":"63","author":"A Tomaschitz","year":"2014","unstructured":"Tomaschitz A, Ritz E, Pieske B, Rus-Machan J, Kienreich K, Verheyen N, et al. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease[J]. Metabolism. 2014;63:20\u201331.","journal-title":"Metabolism"},{"key":"529_CR18","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1681\/ASN.2014070686","volume":"26","author":"HH Malluche","year":"2015","unstructured":"Malluche HH, Blomquist G, Monier-Faugere MC, Cantor TL, Davenport DL. High parathyroid hormone level and osteoporosis predict progression of coronary artery calcification in patients on dialysis[J]. J Am Soc Nephrol. 2015;26:2534\u201344.","journal-title":"J Am Soc Nephrol"},{"key":"529_CR19","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/ckj\/sfv073","volume":"8","author":"LL Di","year":"2015","unstructured":"Di LL, Gorini A, Bellasi A, Morrone LF, Rivera R, Russo L, et al. Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease[J]. Clin Kidney J. 2015;8:732\u20136.","journal-title":"Clin Kidney J"},{"key":"529_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/jhh.2015.21","volume":"30","author":"Q Luo","year":"2016","unstructured":"Luo Q, Li NF, Yao XG, Zhang DL, Abulikemu SFY, Chang GJ, et al. Potential effects of age on screening for primary aldosteronism[J]. J Hum Hypertens. 2016;30:53.","journal-title":"J Hum Hypertens"},{"key":"529_CR21","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1097\/00004872-200311000-00002","volume":"21","author":"JA Whitworth","year":"2003","unstructured":"Whitworth JA. World Health Organization (WHO)\/International Society of Hypertension (ISH) statement on management of hypertension[J]. J Hypertens. 2003;21:1983\u201392.","journal-title":"J Hypertens"},{"key":"529_CR22","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/iju.13060","volume":"23","author":"N Fujita","year":"2016","unstructured":"Fujita N, Hatakeyama S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, et al. Implication of aortic calcification on persistent hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism[J]. Int J Urol. 2016;23:412\u20137.","journal-title":"Int J Urol"},{"key":"529_CR23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrneph.2013.110","volume":"9","author":"NJ Brown","year":"2013","unstructured":"Brown NJ. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis[J]. Nat Rev Nephrol. 2013;9:459.","journal-title":"Nat Rev Nephrol"},{"key":"529_CR24","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.1016\/j.ijcard.2013.08.022","volume":"168","author":"F Mayyas","year":"2013","unstructured":"Mayyas F, Alzoubi KH, Van Wagoner DR. Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural\/electrical remodeling[J]. Int J Cardiol. 2013;168:5135\u201342.","journal-title":"Int J Cardiol"},{"key":"529_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1152\/ajprenal.00435.2007","volume":"295","author":"JT Mathew","year":"2008","unstructured":"Mathew JT, Patni H, Chaudhary AN, Liang W, Gupta A, Chander PN, et al. Aldosterone induces mesangial cell apoptosis both in vivo and in vitro[J]. Am j physiol Ren physiol. 2008;295:73\u201381.","journal-title":"Am j physiol Ren physiol"},{"key":"529_CR26","doi-asserted-by":"publisher","first-page":"E209","DOI":"10.1152\/ajpendo.2001.280.2.E209","volume":"280","author":"G Mazzocchi","year":"2001","unstructured":"Mazzocchi G, Aragona F, Malendowicz LK, Nussdorfer GG. PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells[J]. Am J Physiol Endocrino Metab. 2001;280:E209\u2013E213.","journal-title":"Am J Physiol Endocrino Metab"},{"key":"529_CR27","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1093\/ps\/84.9.1463","volume":"84","author":"M Kawashima","year":"2005","unstructured":"Kawashima M, Takahashi T, Yanai H, Ogawa H, Yasuoka T. Direct action of parathyroid hormone-related peptide to enhance corticosterone production stimulated by adrenocorticotropic hormone in adrenocortical cells of hens[J]. Poult Sci. 2005;84:1463\u20139.","journal-title":"Poult Sci"},{"key":"529_CR28","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1158\/1055-9965.EPI-07-2924","volume":"17","author":"M Rizk-Rabin","year":"2008","unstructured":"Rizk-Rabin M, Assie G, Rene-Corail F, Perlemoine K, Hamzaoui H, Tissier F, et al. Differential expression of parathyroid hormone\u2013related protein in adrenocortical tumors: autocrine\/paracrine effects on the growth and signaling pathways in H295R Cells[J]. Cancer Epidemiol Biomark Prev. 2008;17:2275\u201385.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"529_CR29","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/HJH.0b013e32834f0451","volume":"30","author":"C Maniero","year":"2012","unstructured":"Maniero C, Fassina A, Seccia TM, Toniato A, Rossi GP. Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism[J]. J Hypertens. 2012;30:390\u20135.","journal-title":"J Hypertens"},{"key":"529_CR30","doi-asserted-by":"publisher","first-page":"E75","DOI":"10.1210\/jc.2011-2183","volume":"97","author":"S Pilz","year":"2012","unstructured":"Pilz S, Kienreich K, Drechsler C, Ritz E, Fahrleitner-Pammer A, Gaksch M, et al. Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study[J]. J Clin Endocrinol Metab. 2012;97:E75\u2013E79.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1 Pt 1","key":"529_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0895-7061(97)00366-X","volume":"11","author":"E Rossi","year":"1998","unstructured":"Rossi E, Perazzoli F, Negro A, Sani C, Davoli S, Dotti C, et al. Acute effects of intravenous sodium chloride load on calcium metabolism and on parathyroid function in patients with primary aldosteronism compared with subjects with essential hypertension[J]. Am J Hypertens. 1998;11(1 Pt 1):8.","journal-title":"Am J Hypertens"},{"key":"529_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.4103\/0019-5413.114932","volume":"47","author":"S Kota","year":"2013","unstructured":"Kota S, Jammula S, Kota S, Meher L, Modi K. Correlation of vitamin D, bone mineral density and parathyroid hormone levels in adults with low bone density[J]. Indian J Orthop. 2013;47:402\u20137.","journal-title":"Indian J Orthop"},{"key":"529_CR33","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/sj.ki.5002241","volume":"71","author":"KR Neves","year":"2007","unstructured":"Neves KR, Graciolli FG, Dos Reis LM, Graciolli RG, Neves CL, Magalh\u00e3es AO, et al. Vascular calcification: contribution of parathyroid hormone in renal failure[J]. Kidney Int. 2007;71:1262\u201370.","journal-title":"Kidney Int."},{"key":"529_CR34","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.diabet.2017.04.008","volume":"44","author":"A Mary","year":"2018","unstructured":"Mary A, Hartemann A, Brazier M, Aubert CE, Kemel S, Salem JE, et al. Higher parathyroid hormone levels are associated with increased below-the-knee arterial calcification in type 2 diabetes[J]. Diabetes Metab. 2018;44:305\u20138.","journal-title":"Diabetes Metab."},{"key":"529_CR35","first-page":"1754","volume":"15","author":"Z Cheng","year":"2018","unstructured":"Cheng Z, Ye T, Ling Q, Wu T, Wu G, Zong G. Parathyroid hormone promotes osteoblastic differentiation of endothelial cells via the extracellular signal-regulated protein kinase 1\/2 and nuclear factor-\u03baB signaling pathways[J]. Exp Ther Med. 2018;15:1754\u201360","journal-title":"Exp Ther Med."},{"key":"529_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/ncpneph0032","volume":"1","author":"Rachael Williams","year":"2005","unstructured":"Williams Rachael. Parathyroidectomy might reduce cardiovascular calcification in dialysis patients[J]. Nat Clin Pract Nephrol. 2005;1:64\u20135.","journal-title":"Nat Clin Pract Nephrol"},{"key":"529_CR37","first-page":"388","volume":"68","author":"R Krysiak","year":"2011","unstructured":"Krysiak R, Kobielusz-Gembala I, Okopie\u0144 B. Primary aldosteronism in a patient after surgical treatment of primary hyperparathyroidism[J]. Przegl Lek. 2011;68:388\u201390.","journal-title":"Przegl Lek"},{"key":"529_CR38","first-page":"971","volume":"19","author":"A Concistr\u00e9","year":"2015","unstructured":"Concistr\u00e9 A, Petramala L, Zinnamosca L, Settevendemmie A, Corpaci F, Marinelli C, et al. Primary aldosteronism with concurrent primary hyperparathyroidism: clinical case load in a single centre.[J]. Eur Rev Med Pharm Sci. 2015;19:971\u20136.","journal-title":"Eur Rev Med Pharm Sci"},{"key":"529_CR39","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1055\/a-1027-6472","volume":"128","author":"E Asbach","year":"2020","unstructured":"Asbach E, Bekeran M, K\u00f6nig A, Katharina L, Gregor H, Marcus T, et al. Primary and secondary hyperparathyroidism in patients with primary aldosteronism\u2013findings from the german conn\u2019s registry[J]. Exp Clin Endocrinol Diab. 2020;128:246\u201354.","journal-title":"Exp Clin Endocrinol Diab."},{"key":"529_CR40","first-page":"1","volume":"21","author":"X Gao","year":"2019","unstructured":"Gao X, Yamazaki Y, Onodera Y, Ogata H, Omata K, Morimoto R. et al. The crosstalk between aldosterone and calcium metabolism in primary aldosteronism~A possible calcium metabolism-associated aberrant \u201cneoplastic\u201d steroidogenesis in adrenals~[J]. J Steroid Biochem Mol Biol. 2019;21:1\u201337.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"529_CR41","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s10353-016-0457-6","volume":"49","author":"M Deska","year":"2017","unstructured":"Deska M, Romuk E, Segiet OA, Truchanowski W, Stolecka D, Birkner E, et al. Oxidative stress and angiogenesis in primary hyperparathyroidism[J]. Eur Surg. 2017;49:118\u201326.","journal-title":"Eur Surg"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-020-0529-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-020-0529-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-020-0529-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T19:18:10Z","timestamp":1628277490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-020-0529-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["529"],"URL":"https:\/\/doi.org\/10.1038\/s41440-020-0529-7","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,7]]},"assertion":[{"value":"19 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki and its amendments and was approved by the Ethics Committee of People\u2019s Hospital of Xinjiang Uygur Autonomous Region.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants provided signed informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}